BELLEVUE ASSET MANAGEMENT, LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1801619 BELLEVUE, WA

Position in SLS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$37,077

+$26,452 QoQ

Shares Held

2,512

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#157

of 189 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BELLEVUE ASSET MANAGEMENT, LLC holds $175,569 across 3 Biotechnology names. SLS ranks #2 (21.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	700	$131,096
2	SLS	SELLAS Life Sciences Group, Inc. This page	2,512	$37,077
3	ALT	Altimmune, Inc.	2,433	$7,396

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$37,077	2,512	0.0%	Shares	Sole	2026-08-04
2026-03-31	$10,625	2,512	—	Shares	Sole	2026-04-24
No filing history on record for this holder in this stock.